FDA inspection
GlaxoSmithKline Manufacturing S.p.A.: FDA inspection ending Nov 12, 2021
FDA inspection 1160517 · Voluntary Action Indicated (VAI) · Torrile
Key facts
| Inspection ID | 1160517 |
|---|---|
| Firm | GlaxoSmithKline Manufacturing S.p.A. |
| FEI number | 3002807114 |
| Address | Strada Statale 343 Asolana 90 |
| City | Torrile |
| Fiscal year | 2022 |
| Inspection end date | Nov 12, 2021 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data